Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H1.10 is a replication-independent linker histone variant, encoded by the H1-10 (H1FX) gene, and is a member of the histone H1 family[4]. It acts as a chromatin architectural protein by binding to linker DNA between nucleosomes and promoting condensation of nucleosome arrays into higher-order chromatin structures[1][2][3][4][5]. Unlike core histones (H2A, H2B, H3, H4), H1.10 does not form part of the nucleosome "bead," but stabilizes the overall chromatin fiber, regulates DNA accessibility, and thereby modulates gene expression, nucleosome spacing, and chromatin folding[2][3][4]. H1.10 is predominantly expressed in differentiated cells and is considered critical for maintaining genome organization, epigenetic state, and cellular identity[2][4][5]. No drugs are known to specifically target Histone H1.10, and its direct use as a therapeutic target or biomarker is currently not established. Disruption of H1 variants, including H1.10, can significantly impact global chromatin condensation and gene regulation[5]. Key post-translational modifications (e.g., phosphorylation, acetylation, methylation) regulate its chromatin binding dynamics and function[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H1.10 (H1-10).